Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis

References

• Ashok, A. H., Mizuno, Y., Volkow, N. D., & Howes, O. D. (2017). Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: A systematic review and meta-analysis. JAMA Psychiatry, 74, 511–519. doi:10.1001/jamapsychiatry.2017.0135
   PubMed Web of Science ®Google Scholar
• Bramness, J. G., Gundersen, Ø. H., Guterstam, J., Rognli, E. B., Konstenius, M., Løberg, E.-M., … Franck, J. (2012). Amphetamine-induced psychosis–a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry, 12, 221. doi:10.1186/1471-244X-12-221
   PubMed Web of Science ®Google Scholar
• Brecht, M. L., & Herbeck, D. (2013). Methamphetamine use and violent behavior: User perceptions and predictors. Journal of Drug Issues, 43, 468–482. doi:10.1177/0022042613491098
   PubMed Web of Science ®Google Scholar
• Breen, M. S., Uhlmann, A., Ozcan, S., Chan, M., Pinto, D., Bahn, S., & Stein, D. J. (2017). Parallel changes in serum proteins and diffusion tensor imaging in methamphetamine-associated psychosis. Scientific Reports, 7, 43777. doi:10.1038/srep43777
   PubMed Web of Science ®Google Scholar
• Chan, D. W., & Lai, B. (1993). Assessing psychopathology in Chinese psychiatric patients in Hong Kong using the Brief Psychiatric Rating Scale. Acta Psychiatrica Scandinavica, 87, 37–44. doi:10.1111/j.1600-0447.1993.tb03327.x
   PubMed Web of Science ®Google Scholar
• Chen, C.-K., Lin, S.-K., Sham, P. C., Ball, D., Loh, E.-W., Hsiao, C.-C., … Murray, R. M. (2003). Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine, 33, 1407–1414. doi:10.1017/S0033291703008353
   PubMed Web of Science ®Google Scholar
• Darke, S., Kaye, S., Duflou, J., & Lappin, J. (2019). Completed suicide among methamphetamine users: A national study. Suicide and Life-Threatening Behavior, 49, 328–337. doi:10.1111/sltb.12442
   PubMed Web of Science ®Google Scholar
• Dingemans, P. M., Frohn-de Winter, M. L., Bleeker, J. A., & Rathod, P. (1983). A cross-cultural study of the reliability and factorial dimensions of the Brief Psychiatric Rating Scale (BPRS). Psychopharmacology, 80, 190–191. doi:10.1007/BF00427968
   PubMed Web of Science ®Google Scholar
• Giedd, J. N., & Rapoport, J. L. (2010). Structural MRI of pediatric brain development: What have we learned and where are we going? Neuron, 67, 728–734. doi:10.1016/j.neuron.2010.08.040
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards, S., & Mooney, L. J. (2014). Methamphetamine psychosis: Epidemiology and management. CNS Drugs, 28, 1115–1126. doi:10.1007/s40263-014-0209-8
   PubMed Web of Science ®Google Scholar
• Grant, K. M., LeVan, T. D., Wells, S. M., Li, M., Stoltenberg, S. F., Gendelman, H. E., … Bevins, R. A. (2012). Methamphetamine-associated psychosis. Journal of Neuroimmune Pharmacology, 7, 113–139. doi:10.1007/s11481-011-9288-1
   PubMed Web of Science ®Google Scholar
• Guy, W. (1976). ECDEU assessment manual for psychopharmacology, revised. Rockville, MD: US Department of Health and Human Services.
   Google Scholar
• Hartel-Petri, R., Krampe-Scheidler, A., Braunwarth, W. D., Havemann-Reinecke, U., Jeschke, P., Looser, W., … Hamdorf, W. (2017). Evidence-based guidelines for the pharmacologic management of methamphetamine dependence, relapse prevention, chronic methamphetamine-related, and comorbid psychiatric disorders in post-acute settings. Pharmacopsychiatry, 50, 96–104. doi:10.1055/s-0043-105500
   PubMed Web of Science ®Google Scholar
• Hsieh, J. H., Stein, D. J., & Howells, F. M. (2014). The neurobiology of methamphetamine induced psychosis. Frontiers in Human Neuroscience, 8, 537. doi:10.3389/fnhum.2014.00537
   PubMed Web of Science ®Google Scholar
• Ma, J., Li, X.-D., Wang, T.-Y., Li, S.-X., Meng, S.-Q., Blow, F. C., … Lu, L. (2018). Relationship between the duration of methamphetamine use and psychotic symptoms: A two-year prospective cohort study. Drug and Alcohol Dependence, 187, 363–369. doi:10.1016/j.drugalcdep.2018.03.023
   PubMed Web of Science ®Google Scholar
• McKetin, R., Hickey, K., Devlin, K., & Lawrence, K. (2010). The risk of psychotic symptoms associated with recreational methamphetamine use. Drug and Alcohol Review, 29, 358–363. doi:10.1111/j.1465-3362.2009.00160.x
   PubMed Web of Science ®Google Scholar
• McKetin, R., Lubman, D. I., Baker, A. L., Dawe, S., & Ali, R. L. (2013). Dose-related psychotic symptoms in chronic methamphetamine users: Evidence from a prospective longitudinal study. JAMA Psychiatry, 70, 319–324. doi:10.1001/jamapsychiatry.2013.283
   PubMed Web of Science ®Google Scholar
• McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. (2006). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101, 1473–1478. doi:10.1111/j.1360-0443.2006.01496.x
   PubMed Web of Science ®Google Scholar
• Medhus, S., Mordal, J., Holm, B., Morland, J., & Bramness, J. G. (2013). A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards. Psychiatry Research, 206, 17–21. doi:10.1016/j.psychres.2012.09.023
   PubMed Web of Science ®Google Scholar
• Morales, A. M., Kohno, M., Robertson, C. L., Dean, A. C., Mandelkern, M. A., & London, E. D. (2015). Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users. Molecular Psychiatry, 20, 764–771. doi:10.1038/mp.2015.47
   PubMed Web of Science ®Google Scholar
• Overall, L. E., & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799–812. doi:10.2466/pr0.1962.10.3.799
   Web of Science ®Google Scholar
• Overall, J. E., & Rhoades, H. M. (1982). Refinement of phenomenological classification in clinical psychopharmacology research. Psychopharmacology (Berlin), 77, 24–30. doi:10.1007/BF00436095
   PubMed Web of Science ®Google Scholar
• Poloni, N., Zizolfi, D., Ielmini, M., Pagani, R., Caselli, I., Diurni, M., … Callegari, C. (2018). A naturalistic study on the relationship among resilience factors, psychiatric symptoms, and psychosocial functioning in a sample of residential patients with psychosis. Psychology Research and Behavior Management, 11, 123–129. doi:10.2147/PRBM.S159571
   PubMed Web of Science ®Google Scholar
• Shafer, A., Dazzi, F., & Ventura, J. (2017). Factor structure of the Brief Psychiatric Rating Scale - Expanded (BPRS-E) in a large hospitalized sample. Journal of Psychiatric Research, 93, 79–86. doi:10.1016/j.jpsychires.2017.05.011
   PubMed Web of Science ®Google Scholar
• Srisurapanont, M., Arunpongpaisal, S., Wada, K., Marsden, J., Ali, R., & Kongsakon, R. (2011). Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 959–964. doi:10.1016/j.pnpbp.2011.01.014
   PubMed Web of Science ®Google Scholar
• Thompson, P. M., Sowell, E. R., Gogtay, N., Giedd, J. N., Vidal, C. N., Hayashi, K. M., … Toga, A. W. (2005). Structural MRI and brain development. International Review of Neurobiology, 67, 285–323. doi:10.1016/S0074-7742(05)67009-2
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime (UNODC). (2016). World drug report 2016. New York: United Nations.
   Google Scholar
• United Nations Office on Drugs and Grime (UNODC). (2017). World drug report 2017. Vienna: United Nations.
   Google Scholar
• Wang, L. J., Lin, S. K., Chen, Y. C., Huang, M. C., Chen, T. T., Ree, S. C., & Chen, C. K. (2016). Differences in clinical features of nethamphetamine users with persistent psychosis and patients with schizophrenia. Psychopathology, 49, 108–115. doi:10.1159/000445065
   PubMed Web of Science ®Google Scholar
• World Health Organization, Collaborating Centres for Classification of Diseases. (2014). ICD-10: International statistical classification of diseases and related health problems: Version 2014. Geneva: WHO.
   Google Scholar
• World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.
   Google Scholar
• Zhang, Y., Xu, Z., Zhang, S., Desrosiers, A., Schottenfeld, R. S., & Chawarski, M. C. (2014). Profiles of psychiatric symptoms among amphetamine type stimulant and ketamine using inpatients in Wuhan, China. The Journal of Psychiatric Research, 53, 99–102. doi:10.1016/j.jpsychires.2014.02.010
   PubMed Web of Science ®Google Scholar
• Zizolfi, D., Poloni, N., Caselli, I., Ielmini, M., Lucca, G., Diurni, M., … Callegari, C. (2019). Resilience and recovery style: A restrospective study on associations among personal resources, symptoms, neurocognition, quality of life and psychosocial functioning in psychotic patients. Psychology Research and Behavior Management, 12, 385–395. doi:10.2147/PRBM.S205424
   PubMed Web of Science ®Google Scholar